Prof. Dr. Joachim Ewald Kühn

Weitere Beteiligungen

• 28.03.2023

  • Poster
  • P 067

  Variant-specific humoral immune response in an immunocompromised patient experiencing severe, prolonged SARS-CoV-2 infection complicated by escape mutants and self-limiting Omicron re-infection

   Clinical virology
• 28.03.2023

  • Poster
  • P 068

  Detection and differentiation of variant-specific antibodies against the SARS-CoV-2 spike protein using nanoluciferase-tagged RBD- and NTD-antigens in sVNT and capture EIA

   Clinical virology
• 28.03.2023

  • Poster
  • P 238

  A virus-free reporter enzyme assay to identify antiviral drug candidates against SARS-CoV-2 spike protein mediated cell-cell fusion

   Antiviral therapy and resistance, SARS-CoV-2
• 28.03.2023

  • Poster
  • P 036

  Insights into the antiviral activity of Hypericum perforatum extract and its ingredient hypericin

   Antiviral therapy and resistance, SARS-CoV-2
• 30.03.2023

  08:45 – 09:00 12 Min. 3 Min.

  • Abstract Talk
  • O 080

  Cotreatment with Influenza inhibitors and recombinant IFNα as a potential strategy to prevent emergence of drug resistance against direct-acting antivirals

   Antiviral therapy and resistance, Innate immunity